Clinica Baviera S.A.
ISIN
ES0119037010
Ticker
CBAV
Sector
Sub-Industry
Country
Spain
Year Founded
1992
ISIN
ES0119037010
Ticker
CBAV
Sector
Sub-Industry
Country
Spain
Year Founded
1992
Clínica Baviera is a European reference in the diagnosis, treatment and follow-up of all types of ophthalmological disorders. Our state-of-the-art technologies allow us to offer a solution to the problems of myopia, hyperopia, astigmatism and presbyopia. In addition, we are specialists in the medical and surgical treatment of problems derived from cataracts, glaucoma, vitreoretinal pathologies, strabismus, ocular plastic surgery, problems of the periocular area, neuro-ophthalmology and corneal diseases. We have a network of more than 90 clinics in four European countries (Spain, Germany, Austria and Italy) and a medical staff of more than 200 ophthalmologists, who have performed more than one million treatments.
200
Europe
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 |
|---|---|---|---|---|
| Assets | N/A | 120,921,729.00 | N/A | 133,809,191.00 |
| Noncurrent Assets | N/A | 89,543,855.00 | N/A | 95,886,460.00 |
| Property Plant And Equipment | N/A | 71,402,884.00 | N/A | 77,253,249.00 |
| Goodwill | N/A | 14,615,838.00 | N/A | 14,615,838.00 |
| Other Intangible Assets | N/A | 564,265.00 | N/A | 997,795.00 |
| Investment Accounted For Using Equity Method | N/A | 236,855.00 | N/A | 189,894.00 |
| Deferred Tax Assets | N/A | 908,903.00 | N/A | 976,066.00 |
| Other Noncurrent Financial Assets | N/A | 1,815,110.00 | N/A | 1,853,618.00 |
| Current Assets | N/A | 31,377,874.00 | N/A | 37,922,731.00 |
| Inventories | N/A | 1,641,524.00 | N/A | 1,932,946.00 |
| Trade And Other Current Receivables | N/A | 2,279,594.00 | N/A | 3,393,863.00 |
| Current Receivables From Taxes Other Than Income Tax | N/A | 33,503.00 | N/A | 21.00 |
| Current Tax Assets Current | N/A | 63,478.00 | N/A | 53,174.00 |
| Other Current Financial Assets | N/A | 16,113,928.00 | N/A | 22,471,366.00 |
| Cash and cash equivalents | 3,921,368.00 | 10,821,669.00 | N/A | 9,801,026.00 |
| Other Current Assets | N/A | 424,178.00 | N/A | 270,335.00 |
| Equity And Liabilities | N/A | 120,921,729.00 | N/A | 133,809,191.00 |
| Equity | N/A | 44,904,399.00 | 44,904,399.00 | 55,394,068.00 |
| Issued Capital | N/A | 1,630,758.00 | N/A | 1,630,758.00 |
| Retained Earnings | N/A | 23,951,905.00 | N/A | 28,849,606.00 |
| Share Premium | N/A | 4,893,814.00 | N/A | 4,893,814.00 |
| Treasury Shares | N/A | 48,692.00 | N/A | 75,882.00 |
| Equity Attributable To Owners Of Parent | N/A | 44,491,994.00 | N/A | 54,603,670.00 |
| Noncontrolling Interests | N/A | 412,405.00 | N/A | 790,398.00 |
| Noncurrent Liabilities | N/A | 43,669,472.00 | N/A | 42,548,482.00 |
| Other Longterm Provisions | N/A | 1,614,183.00 | N/A | 2,364,790.00 |
| Noncurrent Payables On Social Security And Taxes Other Than Income Tax | N/A | 2,259,879.00 | N/A | 2,739,426.00 |
| Deferred Tax Liabilities | N/A | 346,941.00 | N/A | 292,448.00 |
| Other Noncurrent Financial Liabilities | N/A | 31,138,420.00 | N/A | 33,419,459.00 |
| Noncurrent Portion Of Noncurrent Unsecured Bank Loans Received | N/A | 10,569,928.00 | N/A | 6,471,785.00 |
| Current Liabilities | N/A | 32,347,858.00 | N/A | 35,866,641.00 |
| Other Shortterm Provisions | N/A | 177,864.00 | N/A | 166,294.00 |
| Trade And Other Current Payables | N/A | 9,937,010.00 | N/A | 12,981,067.00 |
| Current Tax Liabilities Current | N/A | 4,222,767.00 | N/A | 2,923,080.00 |
| Other Current Financial Liabilities | N/A | 9,970,333.00 | N/A | 12,336,293.00 |
| Current Unsecured Bank Loans Received And Current Portion Of Noncurrent Unsecured Bank Loans Received | N/A | 5,780,005.00 | N/A | 4,103,230.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
|---|---|---|
| Revenue | 122,625,591.00 | 172,730,250.00 |
| Other Income | 2,257,385.00 | 677,283.00 |
| Other Work Performed By Entity And Capitalised | 0.00 | 515,702.00 |
| Raw Materials And Consumables Used | 15,253,192.00 | 22,000,122.00 |
| Employee Benefits Expense | 48,976,749.00 | 62,048,942.00 |
| Depreciation And Amortisation Expense | 13,545,027.00 | 14,093,894.00 |
| Other Expense By Nature | 26,598,865.00 | 36,318,028.00 |
| Other Gains Losses | 0.00 | 0.00 |
| Profit Loss From Operating Activities | 20,509,143.00 | 39,429,182.00 |
| Finance Income | 8,005.00 | 3,191.00 |
| Finance Costs | 535,091.00 | 458,301.00 |
| Profit Loss Before Tax | 20,186,062.00 | 38,899,356.00 |
| Income Tax Expense Continuing Operations | 6,053,434.00 | 10,967,857.00 |
| Profit (loss) | 14,132,628.00 | 27,931,499.00 |
| Profit Loss Attributable To Owners Of Parent | 13,941,697.00 | 27,389,527.00 |
| Profit Loss Attributable To Noncontrolling Interests | 190,931.00 | 541,972.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Profit (loss) | N/A | 14,132,628.00 | 27,931,499.00 |
| Adjustments For Finance Costs | N/A | 535,091.00 | 458,301.00 |
| Adjustments For Decrease Increase In Other Operating Receivables | N/A | 555,674.00 | -909,103.00 |
| Adjustments For Provisions | N/A | 657,452.00 | 661,268.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | 0.00 | 33,067.00 |
| Other Adjustments To Reconcile Profit Loss | N/A | -1,508,795.00 | 95,052.00 |
| Cash Flows From Used In Operating Activities | N/A | 31,455,529.00 | 46,856,588.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 0.00 | 50,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 7,818,598.00 | 10,575,188.00 |
| Interest Received Classified As Investing Activities | N/A | 8,005.00 | 3,191.00 |
| Cash Flows From Used In Investing Activities | N/A | -21,401,741.00 | -17,081,246.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 190,682.00 | 491,372.00 |
| Payments Of Other Equity Instruments | N/A | 0.00 | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 10,000,000.00 | 0.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 5,905,971.00 | 5,774,917.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 7,026,672.00 | 7,651,984.00 |
| Dividends Paid Classified As Financing Activities | N/A | 0.00 | 17,348,242.00 |
| Interest Paid Classified As Financing Activities | N/A | 123,956.00 | 112,576.00 |
| Cash Flows From Used In Financing Activities | N/A | -3,153,488.00 | -30,795,985.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 6,900,300.00 | -1,020,643.00 |
| Cash and cash equivalents | 3,921,368.00 | 10,821,669.00 | 9,801,026.00 |
Please note that some sums might not add up.
ES0119037010
959800CR1BA43ZK65T94
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.